Published in Cancer Weekly, November 13th, 1995
"Phase II clinical trials conducted in Europe, the United States, and Japan confirm that Campto has significant activity in advanced colorectal cancer," said Dr. Jean-Pierre Armand, one of the principal clinical investigators of Campto at the Institute Gustave Roussy in France.
"There is a growing body of research that indicates Campto is effective both as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.